STRS Ohio’s Oramed Pharmaceuticals ORMP Stock Holding History

STRS Ohio’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$644K	Buy	+133,800	New	+$533K	﹤0.01%	1022
2022 Q2	–	Sell	-5,400	Closed	-$46K	–	2216
2022 Q1	$46K	Sell	5,400 -3,900	-42%	-$40K	﹤0.01%	1954
2021 Q4	$132K	Hold	9,300	–	–	﹤0.01%	1836
2021 Q3	$204K	Buy	9,300 +3,100	+50%	+$52.8K	﹤0.01%	1761
2021 Q2	$82K	Buy	+6,200	New	+$70.9K	﹤0.01%	2019

Other funds holding ORMP

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

STRS Ohio's ORMP Position: Q2 2026 in Review

STRS Ohio opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 133,800 shares worth $644K. The stake represents ﹤0.01% of the portfolio and ranks #1022 among its holdings. This is a return to the name: STRS Ohio previously reported a position in ORMP as recently as Q1 2022.

STRS Ohio first reported a position in ORMP in Q2 2021 and has held it in 5 quarters since. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

STRS Ohio held 133,800 shares of Oramed Pharmaceuticals worth $644K as of Q2 2026.
Oramed Pharmaceuticals was a new STRS Ohio position in Q2 2026.
Oramed Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1022 holding.
STRS Ohio first reported a position in Oramed Pharmaceuticals in Q2 2021 and has held it in 5 quarters since.
84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.